Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retinal Function in DME Treated With Anti-VEGF
NCT07567833Phase 4Recruiting
- Sponsor
- Jaeb Center for Health Research
- Start
- Jul 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 4, open-label trial in diabetic macular edema (DME) (3 arms), sponsored by Jaeb Center for Health Research. Primary endpoints: Multifocal Pupillographic Objective Perimetry Response Delays at 1 year, Area Under the Log Contrast Sensitivity Function at 1 year and 7 more. Started Jul 2026; status: recruiting.
02
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT07567833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07567833.